Troy Wichterman - 04 Nov 2021 Form 3 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: Chief Financial Officer
Signature: /s/ Troy Wichterman
Issuer symbol: BLFS
Transactions as of: 04 Nov 2021
Net transactions value: $0
Form type: 3
Filing time: 15 Nov 2021, 19:00:35 UTC
Next filing: 17 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BLFS	Common Stock						1,286	04 Nov 2021	Direct
holding	BLFS	Common Stock						127	04 Nov 2021	Direct	F1
holding	BLFS	Common Stock						728	04 Nov 2021	Direct	F2
holding	BLFS	Common Stock						14,644	04 Nov 2021	Direct	F3
holding	BLFS	Common Stock						5,680	04 Nov 2021	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BLFS	Employee Stock Option							04 Nov 2021	Common Stock	938	$2.06	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock award granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and vests in equal quarterly installments.
F2	Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.
F3	Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.
F4	Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.
F5	On May 4, 2015, the reporting person was granted an option to purchase 5,000 shares of common stock which vested in full on May 4, 2019 and of which 4,062 of such options have been exercised.